Currently, the labeling of functional food products is highly regulated in Canada. Although certain nutrient content claims and five generic health claims have been allowed, the inability to make additional nutrient content and health claims decreases functional food firms incentives to produce and commercialize new and healthy food products. This, in turn, has consequences for functional food demand, consumer welfare, and health care costs. The primary objective of this thesis is to examine the potential welfare implications of functional food labeling for Canadian society.<p>A benefit cost analysis is conducted to examine a specific case study of omega-3 enriched eggs. The benefit cost analysis evaluates the welfare effects of functional food labeling policy and helps realize the magnitude of potential benefits that could be gained if not for restrictive and complicated labeling regulations. Based on a range of assumptions and using three different scenarios to cover a range of estimates, the health benefits from the reduction in the risk of coronary heart disease due to the current consumption of omega-3 enriched eggs, and the production and labeling-related costs are estimated. By comparing the estimated benefits and costs, the results indicate that the current consumption of omega-3 enriched eggs provides a considerable net economic gain. Therefore, labeling information on health components can contribute to facilitating a healthy lifestyle with reduced medical costs, stimulating agricultural innovation, and increasing economic welfare.<p>Realizing the positive overall impact that the current consumption of omega-3 enriched eggs has on consumers health and economy in Canada, a possible policy that could regulate all eggs to be enriched with omega-3 fatty acids is proposed. This policy could potentially be used to correct not only information asymmetry but also the negative externalities that are created by health and disability insurances. The benefit cost analysis show that the health benefits would be greatly increased while costs would slightly increase due to reduced labeling-related costs. Therefore, the results indicate that the net economic gain is even stronger if the mandatory development of omega-3 enriched eggs were required.

Currently, the labeling of functional food products is highly regulated in Canada. Although certain nutrient content claims and five generic health claims have been allowed, the inability to make additional nutrient content and health claims decreases functional food firms incentives to produce and commercialize new and healthy food products. This, in turn, has consequences for functional food demand, consumer welfare, and health care costs. The primary objective of this thesis is to examine the potential welfare implications of functional food labeling for Canadian society.<p>A benefit cost analysis is conducted to examine a specific case study of omega-3 enriched eggs. The benefit cost analysis evaluates the welfare effects of functional food labeling policy and helps realize the magnitude of potential benefits that could be gained if not for restrictive and complicated labeling regulations. Based on a range of assumptions and using three different scenarios to cover a range of estimates, the health benefits from the reduction in the risk of coronary heart disease due to the current consumption of omega-3 enriched eggs, and the production and labeling-related costs are estimated. By comparing the estimated benefits and costs, the results indicate that the current consumption of omega-3 enriched eggs provides a considerable net economic gain. Therefore, labeling information on health components can contribute to facilitating a healthy lifestyle with reduced medical costs, stimulating agricultural innovation, and increasing economic welfare.<p>Realizing the positive overall impact that the current consumption of omega-3 enriched eggs has on consumers health and economy in Canada, a possible policy that could regulate all eggs to be enriched with omega-3 fatty acids is proposed. This policy could potentially be used to correct not only information asymmetry but also the negative externalities that are created by health and disability insurances. The benefit cost analysis show that the health benefits would be greatly increased while costs would slightly increase due to reduced labeling-related costs. Therefore, the results indicate that the net economic gain is even stronger if the mandatory development of omega-3 enriched eggs were required.

Rheumatoid arthritis (RA) is a major cause of progressive joint damage and disability, and is associated with decline in quality of life, reduced ability to work and increased health care utilisation. The economic consequences of the disease are substantial for the individuals and their families and for the society as a whole. This thesis describes a 5-year follow up of 320 patients with early RA, enrolled between January 1996 and April 1998 in the Swedish multi-centre inception cohort TIRA (early interventions in rheumatoid arthritis). Health status, function and costs were investigated. Predictors of high costs were calculated, and an algorithm was constructed to predict future need for TNFinhibitor treatment in patients not responding to traditional disease-modifying antirheumatic drugs (DMARDs). Clinical and laboratory data, measures of functional capacity and self-reported assessments were collected regularly. In addition, patients completed biannual/annual questionnaires concerning all health care utilisation and days lost from work due to the disease. Within 3 months, improvements were seen regarding all variables assessing disease activity and functional ability, but 15% of the patients had sustained high or moderate disease activity throughout the study period. The scores of ‘health assessment questionnaire’ (HAQ) were similar for men and women at baseline, but had a less favourable course in women, who also had DMARDs more frequently prescribed. Ambulatory care accounted for 76% of the direct costs during the first year. Women had more ambulatory care visits and higher usage of complementary medicine compared to men. Men ≥65 years had low costs compared to younger men and compared to women of all ages. In multiple logistic regression tests, HAQ, high levels of IgM-class rheumatoid factor (RF), and poor hand function increased the odds of incurring high direct costs. Poor hand function and pain increased the odds of incurring high indirect costs. Indirect costs exceeded direct costs all three years. The average direct costs were €3,704 (US$ 3,297) year 1 and €2,652 (US$ 2,360) year 3. All costs decreased over the years, except those for medication and surgery. The indirect costs were €8,871 (US$ 7,895) year 1 and remained essentially unchanged, similarly for both sexes. More than 50% were on sick leave or early retirement at inclusion. Sick leave decreased but was offset by increase in early retirement. 14 patients (5%) were prescribed TNF-inhibitors at the 3- year follow up, thus increasing drug costs substantially. However, they incurred higher costs even before prescription of anti-TNF therapy. At the 5-year follow-up (2001-2003), 31 patients (12%) were prescribed TNFinhibitors. Baseline values of erythrocyte sedimentation rate, C-reactive protein, anti-CCP antibodies and morning stiffness were significantly higher in this group. These patients were also to a larger extent RF-positive and carriers of the ‘shared epitope’ (SE). Anti-TNF treated patients were significantly younger and more often women. For men, a predictive model was constructed using baseline data including SE+ and IgA-RF &gt;100 U/L and anti-CCP &gt;240 U/L yielding a specificity of 98% and a sensitivity of 71%. For women, disease activity score (DAS28) at the 3-month follow-up proved to be a better predictor, and the final model comprised SE+ and 3-month DAS28&gt;5.2, giving a specificity of 95% and a sensitivity of 59%.

In many countries the focus of the employer's health policy has shifted from the emphasis of treating the disease to the preventative paradigm, which focuses more on the promotion of employees' health. Literature indicates that health promotion programmes have various positive consequences. The aim of this research is therefore to establish some physical, physiological and bio-chemical health profiles of colliery executives in South Africa as well as to determine the effect of a physical and a combined physical and health promotion intervention programme on the parameters mentioned above. Finally, this study aims to determine the effect of a physical and a combined physical and health promotion intervention programme on coronary prone South African colliery executives. In this study an availability, non-randomized sample of 143 white male executives from five collieries, aged 26-58 (x 41.7, ± 7.98 years), was used. These collieries are spread over two South African provinces namely Mpumalanga and Gauteng. Subjects who were on medication that could affect their cholesterol, blood pressure and aerobic fitness values were excluded from the study. The following parameters were used in this study: aerobic fitness, shoulder/arm, strength/endurance (push-ups) abdominal strength/endurance (sit-ups), flexibility, fat percentage, waist-and-hip circumference, body mass index, blood pressure, cholesterol, smoking and leisure-time physical activity participation. ANOVA was used for statistical data analysis - providing descriptive and summarising statistics. One-way analysis of variance was used to determine relationships between variables. The Tukey post-hoc test was used to determine whether certain groups differed statistically significant from each other. It is clear from the descriptive data that flexibility (56.7%), sit-ups (39.7%), aerobic fitness (44.8%), fat percentage (31.4%), BMI (35.7%) and WHR (44.7%) fall into the undesired health zone. Regarding the physiological parameter blood pressure, 16.8% (systolic blood pressure) and 21.7% (diastolic blood pressure) fall into the undesired health zone; regarding the bio-chemical parameter cholesterol, 53.2% falls into the undesired health zone. With regard to some parameters, it appears that the experimental group showed statistically significant changes from Test 1 to Test 3, while the control group showed no statistically significant changes. The reason for this may vary from respondent to respondent already showing "normal" baseline values, probably due to their relative young age (Z=41 years) as to programme preferences and programme adherence. It must, however, be kept in mind that only physical, physiological and bio-chemical parameters were assessed. The health promotion activities focused more on the participants' knowledge empowerment. If these parameters were also included in the assessments the "enriched" programme might have provided some advantages that may have led to long term commitment and behaviour change. Physical fdness intervention (control group) is equally effective in addressing the primary coronary risk factors compared to a programme enriched with health promotion activities (experimental group). However, it seems that the experimental group showed a better response as far as lifestyle change (smoking) and physical activity were concerned. Assessment of other psycho-emotional parameters might indicate a different picture. Respectively 11.7% and 7.6% of the experimental and control group stopped smoking while 20.8% and 16.3% of the experimental and control group respectively reported a higher leisure-time physical activity participation. Regarding aerobic fitness and blood pressure, the average baseline values moved from the high risk category to the "normal" category, while the total cholesterol concentration in the post training values decreased with 12.5% and 14.8% in the experimental and control group respectively. / Thesis (Ph.D. (Human Movement Science))--North-West University, Potchefstroom Campus, 2007.

Diss. (sammanfattning) Göteborg : Univ. , 2008. / Härtill 4 uppsatser.

Diss. Linköping : Univ., 2001.

Diss. (sammanfattning) Stockholm : Karol. inst., 2003. / Härtill 4 uppsatser.

Diss. (sammanfattning) Stockholm Karol. inst., 2002. / Härtill 7 uppsatser.

Diss. (sammanfattning) Linköping : Linköpings universitet, 2005. / Härtill 5 uppsatser.

Diss. (sammanfattning) Stockholm : Karolinska institutet, 2007. / Härtill 5 uppsatser.